Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Home on the range where the buffalo roam -- Ignore unavailable to you. Want to Upgrade?

To: D.B. Cooper who wrote (12493)	3/11/2004 11:02:47 AM
From: Boplicity	Respond to of 13815

LOL, I'm just a saw dust maker as it is. wdik G

To: D.B. Cooper who wrote (12493)	3/12/2004 10:09:33 AM
From: D.B. Cooper	Read Replies (1) \| Respond to of 13815

up 10% so far combimatrix.com anyone buying any stocks that I bring up faces the possiblity of black stools and no grandchildren

To: D.B. Cooper who wrote (12493)	3/17/2004 8:18:42 AM
From: D.B. Cooper	Read Replies (1) \| Respond to of 13815

7:12AM CombiMatrix and St. Jude Children's Research Hospital collaborate on Influenza A "Bird Flu" screening (CBMX) 6.01: Co and Acacia Research (CBMX, ACTG) announced today that its CombiMatrix Group and St. Jude Children's Research Hospital have entered into a collaborative research agreement to study the genetic variation in the H9 variant of Influenza A ("Bird Flu"). finance.yahoo.com 7:33AM Given Imaging announces additional reimbursement coverage by Arkansas Blue Cross Blue Shield (GIVN) 30: Co announces that Arkansas Blue Cross Blue Shield has expanded its existing coverage policy to include initial diagnosis in patients with suspected Crohn's disease without evidence of disease on conventional diagnostic tests such as small bowel follow through and upper and lower endoscopy. This policy is effective as of March 1, 2004.